Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,968 | -144,250 | -8,347 | 4,172 | 8,006 |
| Depreciation Amortization | 75,459 | 72,269 | 56,093 | 40,244 | 30,661 |
| Accounts receivable | -11,516 | -7,581 | -4,691 | -12,601 | -17,301 |
| Other Working Capital | -25,493 | -31,701 | -4,600 | -61,747 | -32,423 |
| Other Operating Activity | 47,565 | 45,270 | -65,178 | 31,392 | 34,426 |
| Operating Cash Flow | $-1,953 | $-65,993 | $-26,723 | $1,460 | $23,369 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 105,459 | 19,310 | -133,821 | -67,745 | N/A |
| PPE Investments | -28,752 | -18,793 | -64,142 | -29,096 | -20,029 |
| Net Acquisitions | N/A | N/A | -419,404 | -37,000 | 399 |
| Purchase Of Investment | N/A | N/A | N/A | -25,600 | N/A |
| Other Investing Activity | 0 | 0 | -15,000 | 0 | 0 |
| Investing Cash Flow | $76,707 | $517 | $-632,367 | $-159,441 | $-19,630 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 334,410 | 194,466 | 100,000 |
| Debt Repayment | -70 | -758 | -3,047 | -103,155 | -111,451 |
| Common Stock Issued | 4,624 | 12,587 | 423,213 | 147,603 | 171,976 |
| Other Financing Activity | 0 | 0 | -29,291 | -3,317 | -1,059 |
| Financing Cash Flow | $4,554 | $11,829 | $725,285 | $235,597 | $159,466 |
| Beginning Cash Position | 263,180 | 316,827 | 250,632 | 173,016 | 9,811 |
| End Cash Position | 342,488 | 263,180 | 316,827 | 250,632 | 173,016 |
| Net Cash Flow | $79,308 | $-53,647 | $66,195 | $77,616 | $163,205 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,953 | -65,993 | -26,723 | 1,460 | 23,369 |
| Capital Expenditure | -28,752 | -30,891 | -64,142 | -29,096 | -20,029 |
| Free Cash Flow | -30,705 | -96,884 | -90,865 | -27,636 | 3,340 |